- Home
- IBO vs AWH Comparison
IBO vs AWH Comparison
Compare IBO & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBO
- AWH
- Stock Information
- Founded
- IBO 2018
- AWH 1993
- Country
- IBO United States
- AWH United States
- Employees
- IBO N/A
- AWH N/A
- Industry
- IBO
- AWH Medical/Dental Instruments
- Sector
- IBO
- AWH Health Care
- Exchange
- IBO NYSE
- AWH Nasdaq
- Market Cap
- IBO 16.5M
- AWH 13.5M
- IPO Year
- IBO 2024
- AWH N/A
- Fundamental
- Price
- IBO $2.60
- AWH $0.80
- Analyst Decision
- IBO
- AWH Buy
- Analyst Count
- IBO 0
- AWH 2
- Target Price
- IBO N/A
- AWH $4.40
- AVG Volume (30 Days)
- IBO 64.6K
- AWH 141.0K
- Earning Date
- IBO 11-12-2024
- AWH 11-14-2024
- Dividend Yield
- IBO N/A
- AWH N/A
- EPS Growth
- IBO N/A
- AWH N/A
- EPS
- IBO 0.02
- AWH N/A
- Revenue
- IBO N/A
- AWH $8,923,000.00
- Revenue This Year
- IBO N/A
- AWH $15.56
- Revenue Next Year
- IBO N/A
- AWH $105.32
- P/E Ratio
- IBO $118.52
- AWH N/A
- Revenue Growth
- IBO N/A
- AWH N/A
- 52 Week Low
- IBO $1.22
- AWH $0.73
- 52 Week High
- IBO $3.20
- AWH $5.65
- Technical
- Relative Strength Index (RSI)
- IBO N/A
- AWH 39.97
- Support Level
- IBO N/A
- AWH $0.84
- Resistance Level
- IBO N/A
- AWH $0.94
- Average True Range (ATR)
- IBO 0.00
- AWH 0.08
- MACD
- IBO 0.00
- AWH -0.01
- Stochastic Oscillator
- IBO 0.00
- AWH 25.93
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.